Naga P. Chalasani

Naga P. Chalasani, MD

Associate Dean for Clinical Research

Bio

Dr. Chalasani is considered an authority in the fields of Non-Alcoholic Fatty Liver Disease (NAFLD) and Drug Induced Liver Injury (DILI), two highly significant public health problems.  He has been continuously funded by the National Institutes of Health since 1999.  He is currently the PI for three U01 awards and an R01 award from the National Institutes of Health. He published over 260 original papers, 3 Practice Guidelines, 47 book chapters/review articles, 31 editorials/commentaries, 16 symposium proceedings, and more than 500 abstracts. He has co-edited a textbook with Prof. Gyongyi Szabo titled ‘Alcoholic & Nonalcoholic Fatty Liver Disease – Bench to bedside' (Springer 2015).  He is an elected member of the American Society of Clinical Investigation (ASCI) and the American Association of Physicians (AAP).   He leads a top ranked GI division consisting of 50 faculty physicians, 3 psychologists, 16 subspecialty fellows, and over 100 staff members. He has mentored over 50 trainees and junior faculty members with 19 of his former mentees in faculty positions at major academic centers and 12 are current or former recipients of federal funding. 

Key Publications

Chalasani N, Abdelmalek MF, Loomba R, Kowdley KV, McCullough AJ, Dasarathy S, Neuschwander-Tetri BA, Terrault N, Ferguson B, Shringarpure R, Shapiro D, Sanyal AJ.  Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with NASH.  Liver Int 2019 May; 39(5):924-932

https://www.ncbi.nlm.nih.gov/pubmed/30253043

Connect


(317) 278-0414 


Gastroenterology
Rotary Building, Suite 225 702 Rotary Cir
Indianapolis, IN 46202-5175


  

Titles & Appointments

  • David W. Crabb Professor of Gastroenterology and Hepatology
  • Professor of Medicine
  • Adjunct Professor of Anatomy, Cell Biology & Physiology
  • Chief, Gastroenterology/Hepatology Division